Page last updated: 2024-10-24

carvedilol and Aortic Valve Insufficiency

carvedilol has been researched along with Aortic Valve Insufficiency in 2 studies

Aortic Valve Insufficiency: Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).

Research Excerpts

ExcerptRelevanceReference
"Severe aortic regurgitation was induced by retrograde puncture of the aortic valve leaflets under sonographic guidance in 12-week-old male C57BL/6J mice."1.42Characterization of coronary flow reserve and left ventricular remodeling in a mouse model of chronic aortic regurgitation with carvedilol intervention. ( Ge, J; Qian, J; Wang, X; Wu, J; You, J; Zhu, D; Zou, Y, 2015)
"Carvedilol treatment resulted in less left ventricular hypertrophy and dilatation."1.37Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation. ( Arsenault, M; Couet, J; Lachance, D; Roussel, E; Zendaoui, A, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, X1
Wu, J1
Zhu, D1
You, J1
Zou, Y1
Qian, J1
Ge, J1
Zendaoui, A1
Lachance, D1
Roussel, E1
Couet, J1
Arsenault, M1

Other Studies

2 other studies available for carvedilol and Aortic Valve Insufficiency

ArticleYear
Characterization of coronary flow reserve and left ventricular remodeling in a mouse model of chronic aortic regurgitation with carvedilol intervention.
    Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2015, Volume: 34, Issue:3

    Topics: Animals; Aortic Valve Insufficiency; Carbazoles; Carvedilol; Chronic Disease; Echocardiography; Frac

2015
Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.
    Circulation. Heart failure, 2011, Volume: 4, Issue:2

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Aortic Valve Insufficiency; Atrial Natri

2011